BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16988545)

  • 1. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
    Wiedermann CJ; Kaneider NC
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
    Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
    Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
    Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
    Tagami T
    J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
    Akahoshi T; Kaku N; Shono Y; Yamamoto Y; Takahashi K; Iyonaga T; Momii K; Nishihara M; Maki J; Tokuda K; Yamaura K
    Clin Appl Thromb Hemost; 2022; 28():10760296221135790. PubMed ID: 36380520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Saitoh D; Gando S; Thachil J
    Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
    Kuroda H; Masuda Y
    Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
    Hayakawa M; Kudo D; Saito S; Uchino S; Yamakawa K; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
    Shock; 2016 Dec; 46(6):623-631. PubMed ID: 27548460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited.
    Wiedermann CJ
    J Thromb Haemost; 2018 Mar; 16(3):455-457. PubMed ID: 29316235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
    Iba T; Saitoh D; Wada H; Asakura H
    Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?
    Seam N; Suffredini AF
    Crit Care; 2014 Nov; 18(6):639. PubMed ID: 25673027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of High-dose Antithrombin Supplementation in Patients with Septic Shock and Disseminated Intravascular Coagulation.
    Kim YJ; Ko BS; Park SY; Oh DK; Hong SB; Jang S; Kim WY
    Sci Rep; 2019 Nov; 9(1):16626. PubMed ID: 31719571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of antithrombin concentrate in sepsis.
    Balk R; Emerson T; Fourrier F; Kruse JA; Mammen EF; Schuster HP; Vinazzer H
    Semin Thromb Hemost; 1998; 24(2):183-94. PubMed ID: 9579641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Suggested Link Between Antithrombin Dose and Rate of Recovery from Disseminated Intravascular Coagulation in Patients with Severe Organ Failure.
    Kuroda H; Tatsumi H; Sonoda T; Masuda Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221080942. PubMed ID: 35187966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
    Kienast J; Juers M; Wiedermann CJ; Hoffmann JN; Ostermann H; Strauss R; Keinecke HO; Warren BL; Opal SM;
    J Thromb Haemost; 2006 Jan; 4(1):90-7. PubMed ID: 16409457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
    Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
    Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.